➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Moodys
Baxter
Colorcon

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Patent: 5,004,736

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,004,736
Title: Procedure for obtaining the preparation for the treatment of the disease psoriasis: drug for the treatment of psoriasis and its application
Abstract:The invention refers to the obtaining of the preparation for the treatment of the skin disease psoriasis. The object of the invention is a medicinal agent based on two corticosteroids, salicylates and antibiotics which clear the skin from psoriasis effectively, the most quickly and without endangering the integrity of healthy organs and skin regions and relapses approximate to zero point. The procedure according to the invention consists of the preparation of emulsion consisting of previously sterilized oil phase and water, to which are then added solutions of the active ingredients in such a way that all the phases are completed according to the order principle of ingredient stability to specified temperatures.
Inventor(s): Visnjic; Pero (58300 Makarska, YU)
Assignee:
Application Number:07/370,121
Patent Claims:see list of patent claims

Details for Patent 5,004,736

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial 2008-04-02 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial 2008-04-02 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Mallinckrodt
AstraZeneca
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.